There’s a reckoning happening in the aesthetics industry, and it’s been a long time coming. After years of heavy filler use, we’re now seeing a profound, undeniable shift toward results that are subtle and balanced. A striking departure from the more-is-more approach that all but defined the last decade.
Patients are still coming in for treatment, but they don’t want anyone to see the work. They just want to look like a better, more refreshed version of themselves.
That shift has changed what good injecting looks like. It’s no longer enough to know where to place filler or how to soften lines with Botox. Today’s best outcomes often come from knowing when filler or neurotoxin isn’t the right answer, and what to reach for instead.
At GAC 2026, you’ll find education built around exactly that challenge, with sessions on regenerative aesthetics, biostimulators, facial anatomy, complication management and combination treatment planning.
Here’s how those pieces are reshaping the modern injector’s toolbox.
The Great Filler Reset
For a long time, the default approach to facial aging was to add volume.
Nasolabial folds? Fill them.
Hollow cheeks? Fill them.
Flat lips? Fill those too.
HA filler was the answer to almost everything, and in a lot of cases, it worked well. But a decade of that approach, applied broadly, has produced a recognizable result: faces that look full but not young, smooth but not natural, and treated in ways that are obvious from across a room.
Patients have noticed. The ones coming in now have seen the overfilled trend on social media and know that’s exactly what they don’t want. Some are asking to have old filler dissolved before they start anything new, while others are requesting results that look like they didn’t have anything done at all. Increasingly, patients want a provider who can assess their features and articulate a strategy that goes beyond “let’s add some filler here.”
We’re not saying you should abandon filler. But the aesthetic toolbox has expanded since 2019, so you can be more selective about when filler is the right answer and when something else might work better, whether that’s PRF, biostimulators, polynucleotides or even nano fat.
Your New Aesthetic Toolbox
What these newer materials have in common is a different “philosophy” than traditional filler. Instead of adding volume, many aim to improve the quality and structure of the skin. Results develop gradually over weeks, so the change never feels too jarring or unfamiliar. Patients just start looking better, and nobody can quite figure out why.
That’s appealing for obvious reasons, but the clinical tradeoff is real. You can’t dissolve PLLA or PRF if you overshoot, for example, and the results develop on a slower timeline. That means an injector who’s built their practice on immediate, visible correction has to adjust not just their injection technique and product selection, but their whole approach to treatment planning.
The payoff is more flexibility across different patient profiles.
A first-time patient and a patient who’s been getting filler for years aren’t starting from the same place. Neither is the patient whose primary concern is skin quality vs. the one who’s lost mid-face volume. When you only have one tool to use, those patients all get some version of the same treatment, but when you can offer biostimulators, PRF and polynucleotides alongside traditional fillers, you can match the approach to what the tissue actually needs.
The clinical thinking gets harder, but the outcomes get better.
Where the Old Playbook Falls Short
One patient population has made the value of a broader toolbox especially clear: people experiencing significant facial changes after GLP-1 weight loss.
When patients lose weight rapidly on semaglutide or tirzepatide, the superficial fat pads that give the face a full, youthful appearance diminish, too. What’s left is loose, deflated skin that can add years to their appearance. Patients are thrilled about the weight loss but disheartened by the facial changes that are now commonly known as “Ozempic face.”
Many injectors treated this deflation the same way they would any other kind of volume loss: by filling it. But for GLP-1 patients, filler alone doesn’t fully address the combination of volume loss, laxity and changing skin quality. In some cases, it can make sagging worse. Seeing where that approach fell short helped clarify the limits of a volume-first strategy.
GLP-1s also brought aesthetic providers an entirely new demographic to work with.
According to McKinsey survey data (2025), 63% of patients seeking facial rejuvenation had no prior history of aesthetic treatments, and about half had never considered treatment before weight loss. Many of these patients are between the ages of 40 and 64 — not the type to be chasing the exaggerated results that defined the “Instagram face” era. They want to look rested, they want the gauntness gone, and they have zero interest in looking “done.”
That combination has forced a more nuanced approach to treatment planning. It’s also made “more tools, used more selectively” feel less like a trend and more of a necessity, since GLP-1 patients often need collagen support, skin tightening and selective volume restoration to achieve their goals and restore a balanced, youthful appearance.
Mo’ Tools, Mo’ Responsibility
Having more tools means more ways to get great results. It also means more ways to create problems you haven’t seen before.
Most injectors have solid training in HA filler complications. Vascular occlusion, overcorrection, asymmetry, and the Tyndall effect are familiar territory. But as the treatment menu expands, so does the range of adverse events you need to learn to recognize and manage. If you’ve added biostimulators and regenerative treatments to your practice over the last few years, it’s worth making sure that your safety training has kept pace with your updated offerings.
A more advanced treatment menu also calls for a more detailed understanding of facial anatomy. The injectors who work confidently with an expanded toolkit tend to be the ones who’ve invested in understanding the deeper anatomical layers, not just the standard injection planes. When you know what sits underneath the needle at every depth, you make better decisions about which tool to use and where to put it.
Go Deeper at GAC 2026
If these are the areas you’re looking to strengthen in your own practice, GAC 2026 gives you four days to build that expertise, with injection sessions that cover everything from foundational filler technique and regenerative aesthetics to advanced anatomy and complication management. Here are the highlights:
Thursday, November 5
- Approach to Addressing Volume Loss in GLP-1 Patients
- Michael Somenek, MD
- Panel: Complications of Injections
- Allergan Injection Session
Friday, November 6
- The Metabolically Optimized Face: Regenerative Aesthetic Strategies for the GLP-1 And Longevity Patient
- Olga Gilman, MD
- Peptides, Exosomes and Biostimulatory Treatments
- Jenna Hilton, PA-C
- Galderma Injection Session
Saturday, November 7
- From Chair to Vanity: Integrating Evidence-Based Skincare With Injectables
- Lycia Thornburg, MD
- What Surgeons See That Injectors Don’t: Lessons From the Operating Room
- Lacey Wilson, MD
- Panel: Regenerative Aesthetics Is Evolving: What’s the Latest?
Sunday, November 8
- Top 10 Complications to Avoid When Treating Facial Asymmetry
- Roxane Scemla, MD
- Nanofat – Top 10 Pearls!
- Randy Miller, MD
- Tips For Lips and Under Eye Fillers
- Jennifer Hollander, MD
Register for GAC 2026: November 5 to 8 in Miami Beach
The injection landscape is moving fast. The materials are changing, the patients are changing, and the complications are changing with them. GAC 2026 offers four days of programming designed to sharpen your clinical judgment, expand your treatment possibilities and elevate your expertise. Register today and secure your spot!
